Kancera presents the company and its projects at Cambridge Innovation Center in Boston (MA) USA on Friday April 27th, 2012. The overall topic of the seminar is “Lead Generation and Structure-Based Drug Design in Cancer Research”.

Chief Operating Officer Dr Martin Norin will describe how structural information and close interaction between clinical expertise and the drug discovery engine of iNovacia, Kancera’s wholly-owned daughter company, is of key importance in guiding the Kancera PFKFB3 and ROR programs.

Also presenting at the seminar is Professor Stefan Knapp, Group Leader of Chemical Biology at the Structural Genomics Consortium (SGC) in Oxford, UK, and Dr Charles Kung, Senior Scientist at Boston-based Agios Pharmaceuticals.

For more information about the event can be found at http://inovacia.se/boston-seminar.